4//SEC Filing
Franklin Joshua B 4
Accession 0001209191-12-043747
CIK 0001145404other
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 3:01 PM ET
Size
9.4 KB
Accession
0001209191-12-043747
Insider Transaction Report
Form 4
Franklin Joshua B
VP, Sales and Marketing
Transactions
- Exercise/Conversion
Common Stock
2012-08-29$3.90/sh+38,637$150,684→ 59,581 total - Exercise/Conversion
Option to Purchase Common Stock (Right to Buy)
2012-08-29−38,637→ 0 totalExercise: $3.90From: 2009-07-28Exp: 2018-10-31→ Common Stock (38,637 underlying) - Sale
Common Stock
2012-08-29$6.86/sh−38,637$265,050→ 20,944 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.85 to $6.93, inclusive. The reporting person undertakes to provide to Cornerstone Therapeutics Inc., any security holder of Cornerstone Therapeutics Inc., or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]Vesting of this option was accelerated, in connection with the closing of the transactions contemplated by the Stock Purchase Agreement, by and among Chiesi Farmaceutici SpA, ("Chiesi") and Cornerstone BioPharma Holdings, Ltd., and other related agreements entered into on May 6, 2009.
Documents
Issuer
CORNERSTONE THERAPEUTICS INC
CIK 0001145404
Entity typeother
Related Parties
1- filerCIK 0001452285
Filing Metadata
- Form type
- 4
- Filed
- Aug 29, 8:00 PM ET
- Accepted
- Aug 30, 3:01 PM ET
- Size
- 9.4 KB